EPM301 not only modulated energy utilization, but also restored glucose and insulin homeostasis as well as reduced obesity-induced hepatic steatosis and liver injury, and normalized hyperlipidemia, an effect that is most likely modulated via affecting cellular hepatic LDL metabolism. This evidence concerns the gene INS and obesity disorder.